1. Simvastatin-ezetimibe and aortic valve stenosis: No benefit with unforeseen harm?

   • José M. Ordovas

   Clinical Trials Report 24 December 2008 Pages: 3 - 4

2. Postprandial lipemia, diet, and cardiovascular risk

   • Angela A. Rivellese
   • Lutgarda Bozzetto
   • Giovanni Annuzzi

   OriginalPaper 24 December 2008 Pages: 5 - 11

3. Genomewide association studies and lipid risk factors

   • Ralph Burkhardt
   • Eimear E. Kenny
   • Jan L. Breslow

   OriginalPaper 24 December 2008 Pages: 12 - 17

4. Circulating oxidized lipoproteins and cardiovascular risk

   • Hiroyuki Itabe

   OriginalPaper 24 December 2008 Pages: 18 - 22

5. Biomarkers of atherosclerosis: Clinical applications

   • Todd M. Brown
   • Vera Bittner

   OriginalPaper 24 December 2008 Pages: 23 - 30

6. Cardiovascular disease is prevented over the long term by better blood glucose control

   • James B. Meigs
   • Frederick A. Masoudi

   Clinical Trials Report 24 December 2008 Pages: 33 - 34

7. Diabetes and stroke

   • Rohit R. Das
   • Sudha Seshadri

   OriginalPaper 24 December 2008 Pages: 35 - 41

8. Cardiovascular risk-benefit ratio of thiazolidinediones

   • Kasia Lipska
   • Silvio E. Inzucchi

   OriginalPaper 24 December 2008 Pages: 42 - 50

9. Microvascular changes in the retina as a risk marker for cardiovascular disease

   • Ning Cheung
   • Tien Y. Wong

   OriginalPaper 24 December 2008 Pages: 51 - 58

10. HIV, insulin resistance and cardiovascular disease

    • Katherine Samaras

    OriginalPaper 24 December 2008 Pages: 59 - 64

11. Polycystic ovary syndrome and cardiovascular disease risk

    • Richard S. Legro

    OriginalPaper 24 December 2008 Pages: 65 - 70

12. Disease management strategies to optimize cardiovascular risk in type 2 diabetes mellitus

    • Patrick J. O’Connor
    • JoAnn M. Sperl-Hillen
    • Thomas E. Kottke

    OriginalPaper 24 December 2008 Pages: 71 - 77